Bekhti A, Rutgeerts L
Postgrad Med J. 1979;55 Suppl 1:30-2.
Forty patients who were suffering from chronic dyspepsia, diagnosed clinically and radiologically as being related to delayed gastric emptying, were treated with either domperidone or placebo in a double-blind trial. The trial lasted four weeks and the dose of domperidone was 10 mg orally t.d.s. before meals. The results showed that the drug markedly improved symptoms and that side effects were few, being recorded in one patient only, on active treatment. It is concluded that domperidone is a useful agent for the treatment of dyspepsia with retarded gastric emptying.
40例患有慢性消化不良的患者，经临床和放射学诊断为与胃排空延迟有关，在一项双盲试验中接受多潘立酮或安慰剂治疗。试验持续4周，多潘立酮的剂量为饭前口服10毫克，每日3次。结果表明，该药物显著改善了症状，且副作用很少，仅1例接受活性治疗的患者出现副作用。结论是，多潘立酮是治疗胃排空延迟性消化不良的有效药物。
